< Back to companies
Proteocyte AI is focused in the computational pathology sector, combing artificial intelligence and protein biomarkers to determine a patient’s 5-year risk of developing cancer. This is technology that predicts who is at risk to develop cancer before they actually have cancer.
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2011
- Website
- proteocyte.com/
Categories
AI / MLCancer
Disease Areas
Technologies
Predictive AnalyticsAI/Machine LearningDiagnostic Platforms
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowWhat do you think of Proteocyte AI?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now